cyclopentyl(thiophen-2-ylmethyl)carbamic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester | 439910-19-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 奎宁环
• 英文名称: cyclopentyl(thiophen-2-ylmethyl)carbamic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester
• 英文别名: [(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-cyclopentyl-N-(thiophen-2-ylmethyl)carbamate
• CAS: 439910-19-7
• 化学式: C₁₈H₂₆N₂O₂S
• 分子量: 334.483
• InChiKey: YOQUTGNBIRSXNF-KRWDZBQOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.72
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  cyclopentyl(thiophen-2-ylmethyl)carbamoyl chloride 、 sodium (R)-quinuclidin-3-ol 以 甲苯 为溶剂， 反应 5.0h， 以33%的产率得到cyclopentyl(thiophen-2-ylmethyl)carbamic acid (3R)-1-azabicyclo[2.2.2]oct-3-yl ester
  参考文献：
  名称：

  [EN] QUINUCLIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
  [FR] NOUVEAUX DERIVES DE LA QUINUCLIDINE ET COMPOSITIONS MEDICINALES LES CONTENANT

  摘要：

  公开号：

  WO2004000840A3

文献信息

• Quinuclidine carbamate derivatives and their use as M3 antagonists
  申请人：——

  公开号：US20040242629A1

  公开（公告）日：2004-12-02

  A compound which is a carbamate of formula: 1 R 2 represents a benzyl, phenethyl, furan-2-ylmethyl, furan-3-ylmethyl, thiophen-2-ylmethyl or thiophen-3-ylmethyl group or a straight or branched alkyl group having 3 to 8 carbon atoms, an alkenyl group having 3 to 8 carbon atoms, or a cycloalkyl group of 3 to 6 carbon atoms; p is 1 or 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; or a pharmaceutically acceptable salt thereof. The pharmaceutically acceptable salt may be of formula: 2

  化合物的化学式为1R2，表示苯甲基、苯乙基、呋喃-2-甲基、呋喃-3-甲基、噻吩-2-甲基或噻吩-3-甲基基团，或具有3至8个碳原子的直链或支链烷基基团，具有3至8个碳原子的烯基基团，或具有3至6个碳原子的环烷基团；p为1或2，氮杂双环环中的取代基可以在2、3或4位，包括所有不对称碳的可能构型；或其药学上可接受的盐。药学上可接受的盐可以是化学式2。
• NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
  申请人：Prat Quinones Maria

  公开号：US20090005412A1

  公开（公告）日：2009-01-01

  Carbamates of formula (I) or pharmaceutically acceptable salts thereof, including quaternary ammonium salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.

  公开了化学式（I）的氨基甲酸酯或其药学上可接受的盐，包括化学式（II）的季铵盐；以及它们的制备方法、包含它们的制药组合物以及它们作为M3胆碱能受体拮抗剂在治疗中的应用。
• NOVEL QUINUCLIDINE CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
  申请人：QUINONES Maria PRAT

  公开号：US20090054480A1

  公开（公告）日：2009-02-26

  Carbamates of formula (I) or pharmaceutically acceptable salts thereof, including quaternary ammonium salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.

  本文披露了式(I)的氨基甲酸酯或其药学上可接受的盐，包括式(II)的季铵盐，以及它们的制备过程、包含它们的制药组合物以及它们作为M3胆碱能受体拮抗剂在治疗中的应用。
• QUINUCLIDINE CARBAMATE DERIVATIVES AND THEIR USE AS M3 ANTAGONISTS
  申请人：Almirall Prodesfarma, S.A.

  公开号：EP1345937A1

  公开（公告）日：2003-09-24
• US7208501B2
  申请人：——

  公开号：US7208501B2

  公开（公告）日：2007-04-24